These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8723466)

  • 1. Penetration and bactericidal activity of cefixime in synovial fluid.
    Somekh E; Heifetz L; Dan M; Poch F; Hafeli H; Tanai A
    Antimicrob Agents Chemother; 1996 May; 40(5):1198-200. PubMed ID: 8723466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
    Owens RC; Tessier P; Nightingale CH; Ambrose PG; Quintiliani R; Nicolau DP
    Int J Antimicrob Agents; 2001 Jun; 17(6):483-9. PubMed ID: 11397619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A; Blandino G; Nicoletti G
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.
    Carsenti-Etesse H; Farinotti R; Durant J; Roger PM; De Salvador F; Bernard E; Rouveix B; Dellamonica P
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):357-66. PubMed ID: 9842977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
    Kumar A; Kelly KJ
    Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
    Rolin O; Roche G; Bouanchaud DH
    Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.
    Bergeron MG; Turcotte A
    Antimicrob Agents Chemother; 1986 Dec; 30(6):913-6. PubMed ID: 3545070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
    Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
    Scaglione F; Demartini G; Dugnani S; Arcidiacono MM; Pintucci JP; Fraschini F
    Br J Clin Pharmacol; 1999 Mar; 47(3):267-71. PubMed ID: 10215750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
    Stone JW; Linong G; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Feb; 23(2):221-8. PubMed ID: 2708180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alteration of bacteria induced by subinhibitory concentrations of cefixime: consequences on bactericidal activity of human polynuclear neutrophils].
    Labro MT; el Benna J; Jemni A
    Pathol Biol (Paris); 1992 May; 40(5):427-32. PubMed ID: 1495824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic and bactericidal characteristics of oral cefixime.
    Brittain DC; Scully BE; Hirose T; Neu HC
    Clin Pharmacol Ther; 1985 Nov; 38(5):590-4. PubMed ID: 4053491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L; Huovinen P
    Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Dabernat H; Geslin P; Megraud F; Bégué P; Boulesteix J; Dubreuil C; de La Roque F; Trinh A; Scheimberg A
    J Antimicrob Chemother; 1998 Feb; 41(2):253-8. PubMed ID: 9533468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study.
    Rosenfeld RM; Doyle WJ; Swarts JD; Seroky J; Greene I
    Ann Otol Rhinol Laryngol; 1993 Mar; 102(3 Pt 1):222-6. PubMed ID: 8457124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis.
    Jafari HS; Sáez-Llorens X; Ramilo O; Shelton SL; McCracken GH
    Antimicrob Agents Chemother; 1991 Feb; 35(2):220-3. PubMed ID: 2024953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.